1. Home
  2. RILYP vs KLTOW Comparison

RILYP vs KLTOW Comparison

Compare RILYP & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RILYP
  • KLTOW
  • Stock Information
  • Founded
  • RILYP 1973
  • KLTOW N/A
  • Country
  • RILYP United States
  • KLTOW United States
  • Employees
  • RILYP N/A
  • KLTOW 3
  • Industry
  • RILYP Investment Managers
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RILYP Finance
  • KLTOW Health Care
  • Exchange
  • RILYP Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • RILYP N/A
  • KLTOW N/A
  • IPO Year
  • RILYP N/A
  • KLTOW 2022
  • Fundamental
  • Price
  • RILYP $4.71
  • KLTOW $0.25
  • Analyst Decision
  • RILYP
  • KLTOW
  • Analyst Count
  • RILYP 0
  • KLTOW 0
  • Target Price
  • RILYP N/A
  • KLTOW N/A
  • AVG Volume (30 Days)
  • RILYP 30.2K
  • KLTOW N/A
  • Earning Date
  • RILYP 01-01-0001
  • KLTOW N/A
  • Dividend Yield
  • RILYP 19.10%
  • KLTOW N/A
  • EPS Growth
  • RILYP N/A
  • KLTOW N/A
  • EPS
  • RILYP N/A
  • KLTOW N/A
  • Revenue
  • RILYP $854,383,000.00
  • KLTOW N/A
  • Revenue This Year
  • RILYP N/A
  • KLTOW N/A
  • Revenue Next Year
  • RILYP N/A
  • KLTOW N/A
  • P/E Ratio
  • RILYP N/A
  • KLTOW N/A
  • Revenue Growth
  • RILYP N/A
  • KLTOW N/A
  • 52 Week Low
  • RILYP $1.73
  • KLTOW N/A
  • 52 Week High
  • RILYP $20.00
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RILYP 82.79
  • KLTOW N/A
  • Support Level
  • RILYP $2.02
  • KLTOW N/A
  • Resistance Level
  • RILYP $4.78
  • KLTOW N/A
  • Average True Range (ATR)
  • RILYP 0.39
  • KLTOW 0.00
  • MACD
  • RILYP 0.31
  • KLTOW 0.00
  • Stochastic Oscillator
  • RILYP 97.70
  • KLTOW 0.00

About RILYP B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: